U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C26H27Cl2NO
Molecular Weight 440.405
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0
Stereo Comments E or Z

SHOW SMILES / InChI
Structure of 2-(2-CHLORO-4-(2-CHLORO-1,2-DIPHENYL-VINYL)PHENOXY)-N,N-DIETHYLETHANAMINE (LOWER MELTING-POINT ISOMER)

SMILES

CCN(CC)CCOC1=C(Cl)C=C(C=C1)C(=C(Cl)C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=UFYSLPYWKZFZJV-OCEACIFDSA-N
InChI=1S/C26H27Cl2NO/c1-3-29(4-2)17-18-30-24-16-15-22(19-23(24)27)25(20-11-7-5-8-12-20)26(28)21-13-9-6-10-14-21/h5-16,19H,3-4,17-18H2,1-2H3/b26-25+

HIDE SMILES / InChI

Molecular Formula C26H27Cl2NO
Molecular Weight 440.405
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 18:10:36 GMT 2023
Edited
by admin
on Sat Dec 16 18:10:36 GMT 2023
Record UNII
4TQR9H79VF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-(2-CHLORO-4-(2-CHLORO-1,2-DIPHENYL-VINYL)PHENOXY)-N,N-DIETHYLETHANAMINE (LOWER MELTING-POINT ISOMER)
Systematic Name English
CLOMIFENE CITRATE IMPURITY H [EP IMPURITY]
Common Name English
Code System Code Type Description
PUBCHEM
121300052
Created by admin on Sat Dec 16 18:10:37 GMT 2023 , Edited by admin on Sat Dec 16 18:10:37 GMT 2023
PRIMARY
FDA UNII
4TQR9H79VF
Created by admin on Sat Dec 16 18:10:37 GMT 2023 , Edited by admin on Sat Dec 16 18:10:37 GMT 2023
PRIMARY
CAS
1795130-17-4
Created by admin on Sat Dec 16 18:10:37 GMT 2023 , Edited by admin on Sat Dec 16 18:10:37 GMT 2023
NON-SPECIFIC STEREOCHEMISTRY
Related Record Type Details
PARENT -> IMPURITY
sum of impurities G and H: maximum 0.15 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
The sum of these geometric isomers is NMT 1.0% and this corresponds to CLOMIFENE CITRATE Impurity GH [EP].
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP